•  
Dainippon Printing's art gallery opened in Kyoto

Dainippon Printing's art gallery opened in Kyoto

KYOTO, Japan - Various reproduced artworks using printing technologies are on display at Dai Nippon Printing Co.'s newly opened Kyoto Uzumasa cultural legacy gallery on the premises of its Kyoto plant, western Japan, on Oct. 9, 2014.

  •  
Dainippon Sumitomo Pharma displays Meiji era equipment

Dainippon Sumitomo Pharma displays Meiji era equipment

OSAKA, Japan - Dainippon Sumitomo Pharma Co. begins displaying equipment for manufacturing medicine and other purposes from the Meiji period at its head office in Osaka on March 25, 2014.

  •  
Dainippon Sumitomo to buy U.S. drugmaker Sepracor for $2.6 bil.

Dainippon Sumitomo to buy U.S. drugmaker Sepracor for $2.6 bil.

TOKYO, Japan - Dainippon Sumitomo Pharma Co. President Masayo Tada speaks about the company's plan to buy U.S. pharmaceutical maker Sepracor Inc. for about $2.6 billion (around 240 billion yen) at a news conference in Tokyo on Sept. 3. Sepracor will become a wholly owned unit of Dainippon Sumitomo Pharma America Holdings Inc., a U.S. subsidiary of the Japanese drugmaker.

  •  
Dainippon Sumitomo to buy out U.S. drugmaker Sepracor

Dainippon Sumitomo to buy out U.S. drugmaker Sepracor

OSAKA, Japan - Photo taken Sept. 3 shows the headquarters of Dainippon Sumitomo Pharma Co. in Osaka. The company said the same day it has agreed to buy out Sepracor Inc., a Massachusetts-based pharmaceutical maker, for around $2.6 billion in an attempt to tap into the U.S. market.

  •  
Drugmakers Dainippon, Sumitomo to merge in Oct. 2005

Drugmakers Dainippon, Sumitomo to merge in Oct. 2005

TOKYO, Japan - Dainippon Pharmaceutical Co. President Kenjiro Miyatake (L) and Sumitomo Pharmaceuticals Co. President Yasuo Okamoto shake hands at a press conference in Tokyo on Nov. 25. The two companies said they have reached a basic agreement to merge Oct. 1, 2005, creating a top-10 pharmaceutical maker in Japan in terms of prescription drug sales.

  •  
Drugmakers Dainippon, Sumitomo to merge in Oct. 2005

Drugmakers Dainippon, Sumitomo to merge in Oct. 2005

TOKYO, Japan - Dainippon Pharmaceutical Co. President Kenjiro Miyatake (L) and Sumitomo Pharmaceuticals Co. President Yasuo Okamoto shake hands at a press conference in Tokyo on Nov. 25. The two companies said they have reached a basic agreement to merge Oct. 1, 2005, creating a top-10 pharmaceutical maker in Japan in terms of prescription drug sales. (Kyodo)

  •  
Shiraito Falls

Shiraito Falls

Shiraito Falls. A branch of the Fuji River, Shiba River becomes a waterfall here. There is a monument with a poem by Kamo Hidetaka : Without knowing the time, water from snow or from heaven, falls perpetually at Shiraito (From the Dainippon Dictionary of Place Names).==Date:unknown, Place:Shizuoka, Photo:unknown, (Credit:Nagasaki University Library/Kyodo News Images) [Cabinet Number13‐29‐0]

  •  
Dainippon Printing's art gallery opened in Kyoto

Dainippon Printing's art gallery opened in Kyoto

KYOTO, Japan - Various reproduced artworks using printing technologies are on display at Dai Nippon Printing Co.'s newly opened Kyoto Uzumasa cultural legacy gallery on the premises of its Kyoto plant, western Japan, on Oct. 9, 2014. (Kyodo)

  •  
Dainippon Sumitomo to buy U.S. drugmaker Sepracor for $2.6 bil.

Dainippon Sumitomo to buy U.S. drugmaker Sepracor for $2.6 bil.

TOKYO, Japan - Dainippon Sumitomo Pharma Co. President Masayo Tada speaks about the company's plan to buy U.S. pharmaceutical maker Sepracor Inc. for about $2.6 billion (around 240 billion yen) at a news conference in Tokyo on Sept. 3. Sepracor will become a wholly owned unit of Dainippon Sumitomo Pharma America Holdings Inc., a U.S. subsidiary of the Japanese drugmaker. (Kyodo)

  •  
Dainippon Sumitomo to buy out U.S. drugmaker Sepracor

Dainippon Sumitomo to buy out U.S. drugmaker Sepracor

OSAKA, Japan - Photo taken Sept. 3 shows the headquarters of Dainippon Sumitomo Pharma Co. in Osaka. The company said the same day it has agreed to buy out Sepracor Inc., a Massachusetts-based pharmaceutical maker, for around $2.6 billion in an attempt to tap into the U.S. market. (Kyodo)

  • Main
  • Top
  • Editorial
  • Creative
  • About Us
  • About ILG
  • Terms of use
  • Company
  • BEHIND
  • Price List
  • Single Plan
  • Monthly Plan
  • Services
  • Shooting
  • Rights Clearance
  • Support
  • FAQ
  • How To Buy
  • Contact Us
  • Become a Partner

© KYODO NEWS IMAGES INC

All Rights Reserved.

  • Editorial
  • Olympics
  • News
  • Sports
  • Japan
  • Tech
  • Royal
  • Disaster
  • NorthKorea
  • Old Japan
  • SNS
  • Creative
  • Food
  • Japan
  • Landscape
  • Animal
  • Popular
  • #Ukraine
  • #China
  • #coronavirus
  • #N. Korea
  • #Thailand
  • #Russia
  • #Ukraine
  • #China
  • #coronavirus
  • #N. Korea
  • #Thailand
  • #Russia
  • Food
  • Japan
  • Landscape
  • Animal
  • Olympics
  • News
  • Sports
  • Japan
  • Tech
  • Royal
  • Disaster
  • NorthKorea
  • Old Japan
  • SNS